JThe following companies are expected to report after-hours earnings on 08/05/2022. See our results calendar for a full list of expected results releases.
Salarius Pharmaceuticals, Inc. (SLRX) reports for the quarter ending June 30, 2022. The pharmaceutical company’s consensus earnings-per-share forecast from the top analyst tracking the stock is -$0.11. This value represents a decrease of 57.14% compared to the same quarter last year. Zacks Investment Research reports that the 2022 P/E ratio for SLRX is -0.43 versus an industry ratio of 2.60.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.